TY - JOUR T1 - Suicide during the COVID-19 pandemic in Japan JF - medRxiv DO - 10.1101/2020.08.30.20184168 SP - 2020.08.30.20184168 AU - Takanao Tanaka AU - Shohei Okamoto Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/11/25/2020.08.30.20184168.abstract N2 - There is an emerging concern that the COVID-19 pandemic could harm psychological health and exacerbate suicide risk. Utilising month-level suicide records covering the entire Japanese population in 1,849 administrative units, we assessed whether suicide mortality changed during the pandemic. Employing difference-in-difference estimation, we found that monthly suicide rates declined by 12% during the initial five months (February to June 2020), which could have been mainly driven by the government’s generous subsidies, reduced working hours, and school closure. In stark contrast, monthly suicide rates increased by 13% in the second wave (July to September 2020), with the magnitude greater among females (29%) and children (49%). The adverse impact of the COVID-19 pandemic may remain, while its modifiers (e.g. government subsidies) may not be sustained for long, suggesting that suicide deaths could keep rising. Hence, effective suicide prevention, particularly among vulnerable populations, should be an important public health consideration.Competing Interest StatementThe authors have declared no competing interest.Funding StatementShohei Okamoto is supported by the postdoctoral fellowship of the Japan Society for the Promotion of Science (No. 20J00394) and the Murata Science Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was not requred as this research is based on secondary analysis of publicly available data.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used in the paper are publicly available. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000140901.html https://github.com/sokamoto-github/Suicide-during-the-Covid-19-pandemic-in-Japan ER -